Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
    • American Diagnosis
    • Where It Hurts
  • Investigations
    • Bill Of The Month
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Payback: Tracking Opioid Cash
    • Systemic Sickness
    • The Injured
    • The Only Hospital in Town
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 1061-1080 of 2,828 results for ""

Sort by

Hospitales ponen en marcha mejores planes luego de enfrentar desastres

By Ana B. Ibarra January 24, 2018 KFF Health News Original

Los hospitales se están preparando para enfrentar mejor los desastres naturales y las tragedias que han puesto a prueba su respuesta a emergencias.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Hospitals’ Best-Laid Plans Upended By Disaster

By Ana B. Ibarra January 24, 2018 KFF Health News Original

An onslaught of fires, shootings and storms across the country last year tested hospital readiness. Now, leaders are using their experiences to address shortcomings that surfaced amid the chaos.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

In Weary Post-Storm Puerto Rico, Medicaid Cutbacks Bode New Ills

By Sarah Varney and Carmen Heredia Rodriguez August 6, 2018 KFF Health News Original

The island’s government must squeeze $840.2 million in annual savings from Medicaid by 2023, part of the U.S. territory’s agreement with the federal government as Puerto Rico claws its way back from fiscal oblivion. Experts warn such drastic cuts defy actuarial science.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Impact Of Drug Prices In TV Ads Mitigated If Consumers Think They Could Be Eligible For Free Treatment

January 24, 2019 Morning Briefing

A new study looked at the effectiveness of the Trump administration’s proposal to require drugmakers to state prices in TV commercials. While putting the costs in did affect consumers, the impact was muted if the ad’s language suggests that some people could get the treatment for free. In other pharmaceutical news: foreign drug pricing, the controversial 340B program, negotiating powers for Medicaid, and more.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Bristol-Meyers Announces $74B Merger With Celgene In Deal Primed To Have Sweeping Implications For Drug Industry

January 4, 2019 Morning Briefing

In the first major pharmaceutical deal of 2019, Bristol-Myers Squibb says it will buy Celgene, a maker of cancer-fighting drugs, in a merger valued at $74 billion. According to Stat, Bristol-Myers has been under pressure to set a new course since August 2016, when a big study of its cancer immunotherapy, Opdivo, failed to show a benefit in previously untreated patients with non-small cell lung cancer. Analysts look at what the deal means to the industry at large.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

As Proton Centers Struggle, A Sign Of A Health Care Bubble?

By Jay Hancock May 2, 2018 KFF Health News Original

Companies pushed proton machines and counted on advertising, doctors and insurers to ensure a steady business treating cancer. But the dollars haven’t flowed in as expected.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Despite GOP Losing Control Of The House, Anti-Abortion Advocates Aren’t Worried About Movement’s Momentum

January 9, 2019 Morning Briefing

With Justice Brett Kavanaugh on the court, the anti-abortion movement is eager to see cases move through the judicial branch. “Our agenda is very focused on the executive branch, the coming election, and the courts,” said Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List. Abortion news comes out of Louisiana, as well.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Podcast: KHN’s ‘What The Health?’ The Long Wait Ends For Short-Term Plan Rules

February 22, 2018 KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Julie Appleby of Kaiser Health News discuss the Trump administration’s proposed regulation that would allow the expansion of short-term health insurance policies that do not comply with all the requirements of the Affordable Care Act. The panelists also talk about federal funding (or not) of public health research around guns.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Drug Giant Eli Lilly To Purchase Tiny Startup In $8B Deal To Get Access To Company’s Cancer Treatments

January 8, 2019 Morning Briefing

The purchase could be very lucrative for Eli Lilly. Loxo Oncology’s drug Vitrakvi was approved by the FDA recently based on evidence that it can shrink tumors in 75 percent of patients whose cancer tests positive for a particular kind of genetic mutation.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Campus Voices: Should Student Health Centers Offer Abortion Pills?

By Ana B. Ibarra and Anna Gorman March 9, 2018 KFF Health News Original

California lawmakers are considering a bill that would require student health centers at all of the state’s four-year public universities to carry the abortion pill. Students at campuses across the state sounded off on the proposal.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

New Health Industry Giant Emerges With Completion Of CVS’ $70B Acquisition Of Aetna

November 29, 2018 Morning Briefing

CVS faces a heavy lift in uniting two complicated companies with very different business models and approaches, but company leaders are optimistic that the merger will cut health care costs and improve consumers’ experience. The deal has been working its way through state and federal regulators for the past year, and finally gained the last go-ahead needed from New York this week.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Heated And Deep-Pocketed Battle Erupts Over 340B Drug Discount Program

By Sarah Jane Tribble November 28, 2017 KFF Health News Original

Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Podcast: KHN’s ‘What The Health?’ It’s Nerd Week

April 12, 2018 KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post discuss the Trump administration’s latest effort to revise rules for next year’s Affordable Care Act marketplaces. They also discuss state efforts to stabilize their individual markets in light of some of the changes being made at the federal level.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk

By Shefali Luthra and Anna Gorman July 3, 2018 KFF Health News Original

It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Si la Corte Suprema revoca Roe vs Wade, 22 estados podrían prohibir el aborto

By Julie Rovner July 10, 2018 KFF Health News Original

La elección del presidente Donald Trump de un juez conservador como candidato a la Corte Suprema podría cambiar el mapa del aborto en el país.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Podcast: ‘What The Health?’ Should You Work For Your Medicaid Coverage?

January 12, 2018 KFF Health News Original

In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss possible new work requirements for Medicaid recipients and the latest on renewing the Children’s Health Insurance Program, plus Rovner interviews Princeton health historian Paul Starr.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Podcast: KHN’s ‘What The Health?’ The State Of The (Health) Union

January 31, 2018 KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Despite Boost In Social Security, Rising Medicare Part B Costs Leave Seniors In Bind

By Judith Graham October 5, 2017 KFF Health News Original

With higher premiums on tap for many Medicare enrollees, here’s help figuring out the particulars of the Part B puzzle and how it affects you.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Reversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be

By Jake Harper, Side Effects Public Media May 16, 2018 KFF Health News Original

Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

After Opioid Overdose, Only 30 Percent Get Medicine To Treat Addiction

By Martha Bebinger, WBUR June 19, 2018 KFF Health News Original

Patients revived from an opioid overdose who get methadone or Suboxone treatment for addiction afterward are much more likely to be alive a year later, says a study published in the Annals of Internal Medicine.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 52
  • 53
  • 54
  • 55
  • 56
  • Next

More From KFF Health News

A photo of Senators John Thune, John Barrasso and Shelley Capito in the US Capitol.

‘MAGA’ Backers Like Trump’s ‘Big Beautiful Bill’ — Until They Learn of Health Consequences

A woman in a blue tshirt with dark hair and red lipstick smiles at the camera. She is seated in front of a blue door

The Price You Pay for an Obamacare Plan Could Surge Next Year

A husband sits at the kitchen table. His wife is seen close on the left of the frame. She is blurred slightly as the camera is focused on the husband.

‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options

A teenage boy and his mother sit on a teal couch, side by side, smiling at one another. A dog is seated on each of their laps.

A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity

KFF

© 2025 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue